That's important, since the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (jeff brown predictions for 2021). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was a breakthrough practically nobody observed. But it's going to have profound ramifications for curing illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of investment opportunities in this area, too. Moving subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (exponential growth). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back possibly substantially before going higher - the legacy report prediction. I've been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were mainly informing readers. However that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. democratic republic. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous terrific personal business on the edge of hitting the public markets And I have actually been dealing with a new method for you to invest even before these companies go public.
This chance has actually been constructing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to schedule your spot for free.
Emma Walsh here, managing editor of the Journal. Regular Diary readers know that tech isn't our usual beat (jeff brown predictions 2021). And when it pertains to tech investing, we leave it to the experts. Thankfully, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (future report). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and much more. These patterns are experiencing rapid development and creating amazing chances for financiers. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown stock predictions 2021. However regardless of what numerous readers might think, this is a trend that's simply getting begun. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (biotech stocks jeff brown). Losing two months of production and sales actually affects how lots of 5G devices are offered in the calendar year. When you think about all of that, offering 250 million systems is amazing. More significantly, the hold-ups triggered by the pandemic created a heap of bottled-up demand. And that need is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - jeff brown predictions for 2021. Which's not my only 5G prediction When I've discussed 5G in the past, I have actually explained its three various phases.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Phase Three, 5G services start to be offered (united states). That's when we start to see applications running on 5G networks. Consider things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summer. This starts something of a virtuous cycle: The majority of people do not truly appreciate the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment opportunities going forward will be enormous. Stepping far from 5G, the next essential technology I predict in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable concept but with our genetic code. "Typos" in our genome can cause disease. CRISPR can fix these "typos." For several years, CRISPR was mostly a niche technology that wasn't well understood. And during that time, there were actually only three companies running in this space. But things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're treating illness and seeing that this innovation simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is successfully a greenfield opportunity.
There's space for many business to exist in this area. bleeding edge. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more genetic editing business will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things occurring at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can precisely predict the folding of a protein based solely on its amino acid series with 92. 4% precision. That's essential since the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however a number of drug therapies produced utilizing this technology. This was one of those advancements that nearly no one discovered. But it's going to have extensive implications for treating disease. And, naturally, there will be lots of investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps considerably prior to going higher. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin - what is the legacy report predicting. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. But at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However no one is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. artificial intelligence. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details is up to date since February 2021, however we could not independently validate this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to select winning technology stocks. He spent more than 25 years investigating innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional viewpoint on the marketplace. He's constantly on the hunt for brand-new chances, and he shares much of his best picks in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he effectively predicted some of the most significant economic events of the previous twenty years. Although he doesn't appear to launch his picks to the general public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal every time, but Jeff Brown's accurate forecasts have earned him legions of dedicated followers. That says a lot about his ability. The Future Report is released by Brownstone Research study, a prominent financial research study publisher. Brownstone Research study uses numerous research services with a wide array of expertises - jeff brown biotech pick.
The business is likewise associated with Bonner & Partners, another well-respected research publisher - jeff brown stock predictions. On its website, Brownstone says its mission is to supply retail investors with professional-grade research study: "For too long, the very best investment research study has not been available to private investors. It has been typically reserved for investment banks, hedge funds, private equity, and high-net-worth clients. diplomatic relations. The mission of Brownstone Research is to make that kind of proprietary research readily available to any financiers aiming to acquire an edge in the marketplaces. The objective is basic to deliver distinct and rewarding investment research found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise functions as the firm's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to offer its customers. After decades of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown predictions for 2021. Whatever he touches relies on gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown believes S.A.V. genetic sequencing companies jeff brown. could be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding two cutting-edge innovations: synthetic intelligence and electric automobiles. Musk hopes the mix will help him develop the very first fully-autonomous, self-driving automobiles ever. It's nothing short of the automotive industry's Holy Grail. As you know, electric vehicles and self-driving automobile stocks have been huge this year, however the Wall Street device has approved hype without much concrete outcome. Despite a drastic increase in competitors over the previous couple of years, Brown still thinks Musk has the very best chance of putting all of it together.
tech could be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transportation. Basically, this innovation would allow you to rent your vehicle as an autonomous, self-driving taxi when you're not using it. You simply leave the automobile and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the earnings. It sounds outrageous, but it could be closed than you believe.